Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2) expression via up regulation of its target gene, 29/October/2013, 6.34 am

Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2) expression via up regulation of its target gene, 29/October/2013, 6.34 am

Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2) expression via up regulation of its target gene, 29/October/2013, 6.34 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2)  expression  via up regulation of its target gene, 29/October/2013, 6.34 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Share
Start Typing